Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma

Clinical trial NCT00124605 · COMPLETED

Trial details

NCT number: NCT00124605
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Multiple Myeloma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2005-04-01
Primary completion: 2009-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.